Precision Med TRI-CON Savings Are Available

Hear presentations from:
Amgen, BMS, GSK, Janssen, NIH, Novartis, Pfizer, Sanofi, Takeda and more...

DISCOUNT REGISTRATION BY FEBRUARY 9

31st Precision Med TRI-CON | March 26-28, 2024 | Hilton San Diego Bayfront | San Diego, California

REGISTER | VIEW PROGRAMS | DOWNLOAD BROCHURE | PRESENT A POSTER

For 3 decades, the Precision Med TRI-CON has served as the leading international meeting place for the diagnostics and precision medicine community. Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and precision health; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including multi-cancer early detection and minimal residual disease testing. Emerging implications of faster and cheaper sequencing, AI and digital tools, and spatial biology and single-cell multiomics in advancing precision medicine will be covered in 2024. Join us in sunny San Diego for the in-person networking and visionary and thought-provoking keynote discussions you've come to expect from the TRI-CON!

Featured Presentation

FIRESIDE CHAT: Artificial Intelligence Innovation for Precision Medicine

Eric Topol, MD, Director, Scripps Research Translational Institute; Executive Vice President and Professor, Scripps Research

Interviewed by:
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University

A visionary at the intersection of medicine and technology, Dr. Eric Topol articulates the big picture for radical improvement in healthcare through personalized and data-driven medicine. Eric published three books, over 1,200 peer reviewed publications, and provides his reasoned perspective on medical AI frequently on social media. We will discuss his views on the current state of precision medicine and artificial intelligence, including generative AI in medicine, diagnostics, and clinical trials.

2024 Precision Med TRI-CON
Conference Programs

	AI in Precision Medicine		Artificial Intelligence in Diagnostics
	Implementing Precision Medicine		Diagnostics Market Access
	At-Home & Point-of-Care Diagnostics		Infectious Disease Diagnostics
	Liquid Biopsy		Multi-Cancer Early Detection
	Spatial Biology		Single-Cell Multiomics

Featured Speakers

	Kari Stefansson CEO deCODE genetics		Mara G. Aspinall Partner, Illumina Ventures; Professor of Practice, Arizona State University
	Anthony Sireci SVP, Diagnostics Development, Loxo Oncology Eli Lilly		Atul Butte Chief Data Scientist University of California Health
	Hoi-Ying Elsie Yu Laboratory Director, Point-of-Care Testing Geisinger Health		Esther Babady Section Head, Clinical Microbiology Memorial Sloan Kettering Cancer Center
	Jeffrey Venstrom CMO GRAIL		Razelle Kurzrock CMO Worldwide Innovative Network for Personalized Cancer Therapy
	Jonathan Carlson Managing Director Microsoft Health Futures		Sonya Makhni Medical Director Mayo Clinic Platform
	Ezra Cohen CMO, Oncology Tempus Labs		Howard Scher Head, Biomarker Development Memorial Sloan Kettering Cancer Center
	Jean-Francois Martini Diagnostics Lead, Oncology Pfizer		Lourdes Barrera Executive Director, Precision Medicine Merck
	Christopher Hartshorn Chief, Digital & Mobile Technologies NCATS		Jai Pandey Head, Global Device Regulatory IVD/CDx Sanofi
	George Vacek Global Head, Genomics Alliances NVIDIA		Larissa May Director, Emergency Medicine Innovation UC Davis Health
	Peter Bach CMO Delfi Diagnostics		Anne Beaubrun VP, Global Health Economics & Outcomes Cepheid
	Yuan Luo Chief AI Officer Northwestern University Feinberg School of Medicine		John Mattison Chief Medical Information Officer Arsenal Capital Partners
	Jennifer Quigley Sr. Director, Precision Diagnostics Novartis		Scott Penberthy Managing Director, Applied AI Google Cloud
	Sudhir Srivastava Chief, Cancer Biomarkers Research NCI		Edward Abrahams President Personalized Medicine Coalition
	Jonathan Beer Sr. Director, Diagnostic Science Bristol Myers Squibb		Jim Almas VP, Clinical Effectiveness LabCorp
	Stacey DaCosta Byfield VP, Genomic Health Economics and Outcomes Optum Labs		Larry Kessler Co-Chair MCED Consortium
	Noah Zimmerman VP, Translational Science Tempus		Mark Gardner SVP, Molecular Genomics Quest Diagnostics
	Lesley Northrop Chief Diagnostic Officer Everly Health		Charles Chiu Director, Clinical Microbiology Laboratory UCSF
	Christopher Conn Director, Diagnostics Strategy Amgen